Stock listing

MEM Stock Price, News, Filings & Events — Memphasys Ltd

Selected listing: MEM · ASX · AUD · AU

This page tracks Memphasys Ltd's MEM:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MEM:ASX. MEM:ASX is the stock-level entry point for investors researching Memphasys Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Memphasys Ltd (Ticker: MEM) is a public company based in Australia, with a market capitalization of approximately AUD 14.95 million. The company focuses on developing innovative technologies in the field of reproductive health. Memphasys aims to enhance the efficiency of assisted reproductive technologies through its proprietary solutions.

MEM:ASXAUDAUUpdated August 21, 2026
Memphasys Ltd logo
Ticker
MEM:ASX
Asset type
Stock
Market cap
$14.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD

Memphasys Ltd MEM:ASX stock context

This page tracks Memphasys Ltd's MEM:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MEM:ASX. MEM:ASX is the stock-level entry point for investors researching Memphasys Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Memphasys Ltd (Ticker: MEM) is a public company based in Australia, with a market capitalization of approximately AUD 14.95 million. The company focuses on developing innovative technologies in the field of reproductive health. Memphasys aims to enhance the efficiency of assisted reproductive technologies through its proprietary solutions.

Latest news from Memphasys Ltd

All Memphasys Ltd news →

Research Memphasys Ltd

Alternate listings